BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 22971222)

  • 1. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.
    Mohanty C; Das M; Sahoo SK
    Expert Opin Drug Deliv; 2012 Nov; 9(11):1347-64. PubMed ID: 22971222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.
    Ma Z; Wang N; He H; Tang X
    J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin, a Compound from Natural Sources, a True Scientific Challenge - A Review.
    Stanić Z
    Plant Foods Hum Nutr; 2017 Mar; 72(1):1-12. PubMed ID: 27995378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary Curcumin: Correlation between Bioavailability and Health Potential.
    Dei Cas M; Ghidoni R
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31500361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short review on chemical properties, stability and nano-technological advances for curcumin delivery.
    Slika L; Patra D
    Expert Opin Drug Deliv; 2020 Jan; 17(1):61-75. PubMed ID: 31810374
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in nanotechnology-based delivery systems for curcumin.
    Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
    Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of curcumin: problems and promises.
    Anand P; Kunnumakkara AB; Newman RA; Aggarwal BB
    Mol Pharm; 2007; 4(6):807-18. PubMed ID: 17999464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of different nanocarriers for encapsulation of curcumin.
    Rafiee Z; Nejatian M; Daeihamed M; Jafari SM
    Crit Rev Food Sci Nutr; 2019; 59(21):3468-3497. PubMed ID: 30001150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Critical Review of the Properties and Analytical Methods for the Determination of Curcumin in Biological and Pharmaceutical Matrices.
    Carolina Alves R; Perosa Fernandes R; Fonseca-Santos B; Damiani Victorelli F; Chorilli M
    Crit Rev Anal Chem; 2019; 49(2):138-149. PubMed ID: 30252504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects.
    Saheb M; Fereydouni N; Nemati S; Barreto GE; Johnston TP; Sahebkar A
    J Cell Physiol; 2019 Aug; 234(8):12325-12340. PubMed ID: 30697728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin encapsulation in nanostructures for cancer therapy: A 10-year overview.
    D'Angelo NA; Noronha MA; Kurnik IS; Câmara MCC; Vieira JM; Abrunhosa L; Martins JT; Alves TFR; Tundisi LL; Ataide JA; Costa JSR; Jozala AF; Nascimento LO; Mazzola PG; Chaud MV; Vicente AA; Lopes AM
    Int J Pharm; 2021 Jul; 604():120534. PubMed ID: 33781887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability.
    Wu X; Xu J; Huang X; Wen C
    Drug Dev Ind Pharm; 2011 Jan; 37(1):15-23. PubMed ID: 20738181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conundrum and therapeutic potential of curcumin in drug delivery.
    Kumar A; Ahuja A; Ali J; Baboota S
    Crit Rev Ther Drug Carrier Syst; 2010; 27(4):279-312. PubMed ID: 20932240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UV Spectrophotometric method for characterization of curcumin loaded nanostructured lipid nanocarriers in simulated conditions: Method development, in-vitro and ex-vivo applications in topical delivery.
    Rapalli VK; Kaul V; Gorantla S; Waghule T; Dubey SK; Pandey MM; Singhvi G
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jan; 224():117392. PubMed ID: 31330421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment.
    Ray A; Rana S; Banerjee D; Mitra A; Datta R; Naskar S; Sarkar S
    Toxicol Appl Pharmacol; 2016 Jan; 290():54-65. PubMed ID: 26612707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Yellow Curry: Assessing Commercial Curcumin Absorption Technologies.
    Douglass BJ; Clouatre DL
    J Am Coll Nutr; 2015; 34(4):347-58. PubMed ID: 25856323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bioavailability of curcumin: problems and advancements.
    Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
    J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in curcumin nanoformulation for cancer therapy.
    Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin.
    Chaurasia S; Patel RR; Chaubey P; Kumar N; Khan G; Mishra B
    Carbohydr Polym; 2015 Oct; 130():9-17. PubMed ID: 26076595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties, Extraction Methods, and Delivery Systems for Curcumin as a Natural Source of Beneficial Health Effects.
    Zielińska A; Alves H; Marques V; Durazzo A; Lucarini M; Alves TF; Morsink M; Willemen N; Eder P; Chaud MV; Severino P; Santini A; Souto EB
    Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32635279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.